DoseSpot
Electronic prescribing and EPCS
DoseSpot provides electronic prescribing inside healthcare applications, with controlled-substance prescribing, benefit checks, and prior authorization.
Best for
- EHR and telehealth vendors embedding prescribing in their software
- Organizations that need controlled-substance prescribing within a connected workflow
Not ideal for
- Teams expecting an integration to remove all prescriber enrollment work
- Operators without a contingency plan for prescribing interruptions
Bottom line
DoseSpot is worth evaluating for organizations that want prescribing inside their existing clinical software. Its functional breadth is useful, but the implementation decision should include support responsiveness, prescriber administration, and a workable process for service interruptions.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Software vendors and digital care organizations use DoseSpot to add electronic prescribing to their own applications. DrFirst is a genuine alternative for the eRx and electronic prescribing of controlled substances (EPCS) decision. DoseSpot’s appeal is the connection between an existing patient record, a prescriber, and the pharmacy workflow.
This is a contracted software integration, with engineering and enrollment costs alongside the license. Comparing the complete implementation is more useful than comparing a nominal prescriber fee. The same proposal should account for EPCS identity checks, pharmacy and benefit connections, testing, ongoing support, and any separate add-ons.
- Prescribing workflow value (7.0): Embedded prescribing reduces separate data entry, while published user accounts describe uneven reliability and support.
- eRx and affordability tools (8.0): Controlled-substance prescribing, prior authorization, and benefit information cover the core prescription workflow.
- Integration and support (6.5): Integration options are established, but identity checks, configuration, and issue resolution can delay operations.
- Pricing clarity (5.8): A complete public price schedule was not available.
Prescribing Within Another Application
DoseSpot describes an integrated prescribing platform with patient information, controlled-substance prescribing, electronic prior authorization, and real-time prescription benefit information. Its patient-facing functionality also supports medication affordability and pharmacy choice. These functions can reduce switching between systems during a visit.
The practical value depends on how the host application passes patient data, displays medication history, and handles failed or delayed requests. Public Capterra accounts include praise for integration and easier renewal, alongside complaints about latency, support, and administrative controls. Those accounts span different implementations and dates, so a demonstration should use the intended application and prescriber roles.
What the Interra Merger Changes
DoseSpot and Arrive Health merged into Interra Health in March 2026. The combination connects DoseSpot’s prescribing technology with Arrive’s coverage and affordability network. Josh Weiner, formerly DoseSpot’s CEO, became CEO of the combined company.
The DoseSpot branded site remains active and describes the eRx and EPCS product. The merged network creates an opportunity for broader benefit and pharmacy information, but a purchaser should confirm which capabilities are available in the specific integration being contracted. Announced company-wide reach is not the same as access to every feature in every customer deployment.
Product and service details: dosespot.com, capterra.com.
Company scale
HIR estimates 2026 revenue for the combined Interra Health business at roughly $100 million to $200 million, based on executives’ March 2026 projection of more than $100 million and reported growth. Scale source
What People Say
What people like
"The integration of DoseSpot with our native CRM was seamless, and they provided us with several Admin level tools to carefully and easily manage our ever growing provider user base."
"Ease of renewing prescriptions is simple, a few clicks. Saves a lot of time for patients on maintenance meds."
What people don't like
"The lack of customer service responsiveness."
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| DoseSpot | 7.0 | 6.5 |
| DrFirst | 7.5 | 7.2 |
Pricing
| Item | Detail |
|---|---|
| Commercial terms | Request an integration and prescriber quote; the homepage does not publish a complete rate schedule. |
| Implementation | Include certification, engineering, testing, identity proofing, and EPCS activation. |
| Ongoing scope | Confirm support, benefit checks, prior authorization, and any usage-based charges. |
| Continuity | Agree escalation procedures and responsibilities when a prescription cannot be sent. |
Recent news
- March 2026: DoseSpot and Arrive Health merged to form Interra Health, with Josh Weiner leading the combined company.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- dosespot.com ·
- capterra.com · p/163486/DoseSpot Plus/reviews
- fiercehealthcare.com · health tech/dosespot and arrive health merge build prescription drug access and affordability